HLX3901

· Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLX3901, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC [Phase 1]

See pricing